Evidence map›Paper›PMID 40549770›Full record

ArticleJournal of visualized experiments : JoVE2025

Comprehensive Analysis of Drug Response using the FLICK Assay.

Gavin A Birdsall, Michael J Lee

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gavin A BirdsallDepartment of Systems Biology, UMass Chan Medical School.
Michael J LeeDepartment of Systems Biology, UMass Chan Medical School; michael.lee@umassmed.edu.

Funding

Systems and Network-level Regulation of Cell DeathR35GM152194 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Michael Jungho Lee · 2024 to 2026
$1.3M
Characterization of drug mechanisms of lethality in vivoR21CA294000 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEE, MICHAEL JUNGHO · 2024 to 2024
$431k
NCI NIH HHS R21 CA294000NIGMS NIH HHS R35 GM152194
6 · The paper itself

Abstract

For understanding drug efficacy, a critical need is to characterize the extent of drug-induced cell death. Efforts to quantify the level of drug-induced cell death are challenged by the existence of more than a dozen molecularly distinct forms of regulated death, each with its own activation timing and biochemical hallmark features. Furthermore, for some necrotic death subtypes, hallmark features are only observed transiently and are rapidly lost due to cell rupture. Thus, even when using a combination of death pathway-specific assays, it is challenging to accurately quantify the total amount of cell death or the relative contributions of each death subtype. Another issue is that many death-specific assays ignore how drugs affect cell proliferation, making it challenging to interpret if a drug-treated population is expanding or shrinking. The FLICK assay allows for quantification of the total level of cell death following stimulation in a manner that is specific to death but also largely agnostic to the type(s) of death activated. Additionally, the FLICK assay retains information about the total population size and cell proliferation rate. In this manuscript, we describe the basic use of the FLICK assay, how to troubleshoot this assay when using different types of biological material, and how to use the FLICK assay to quantify the contributions of each type of cell death to an observed drug response.

Indexed as

Cell DeathHumans

Identifiers

PMID40549770
PMCPMC12279393

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.